Ibrutinib plus anti-CD20-interferon alpha fusion protein for treatment of B cell lymphomas.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: University of California, Los Angeles
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891695643
